Catabasis Pharmaceuticals Inc (NASDAQ:CATB)

0.6999
Delayed Data
As of Oct 19
 +0.0084 / +1.21%
Today’s Change
0.61
Today|||52-Week Range
2.41
-53.03%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Catabasis Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.50. The median estimate represents a +328.63% increase from the last price of 0.70.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Catabasis Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$0.00
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.60%
 
 
 
 
 
 
Growthannually 47.07%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.